Speedel CEO Alice Huxley: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses Novartis’ hypertension treatment, Tekturna, which Speedel developed, as well as the benefits of other renin inhibitors in the Swiss biotech’s pipeline.